These authors contributed equally to this work.
Mutation Analysis of CCM1, CCM2 and CCM3 Genes in a Cohort of Italian Patients with Cerebral Cavernous Malformation
Article first published online: 4 OCT 2010
© 2010 The Authors; Brain Pathology © 2010 International Society of Neuropathology
Volume 21, Issue 2, pages 215–224, March 2011
How to Cite
D'Angelo, R., Marini, V., Rinaldi, C., Origone, P., Dorcaratto, A., Avolio, M., Goitre, L., Forni, M., Capra, V., Alafaci, C., Mareni, C., Garrè, C., Bramanti, P., Sidoti, A., Retta, S. F. and Amato, A. (2011), Mutation Analysis of CCM1, CCM2 and CCM3 Genes in a Cohort of Italian Patients with Cerebral Cavernous Malformation. Brain Pathology, 21: 215–224. doi: 10.1111/j.1750-3639.2010.00441.x
- Issue published online: 27 JAN 2011
- Article first published online: 4 OCT 2010
- Accepted manuscript online: 31 AUG 2010 06:42AM EST
- Received 22 April 2010; accepted 13 August 2008.
Vol. 21, Issue 3, 360, Article first published online: 14 APR 2011
- brain vascular pathologies;
- CCM genes;
- cerebral cavernous malformation;
- molecular genetic analysis in Italian patients
Cerebral cavernous malformations (CCMs) are vascular lesions of the CNS characterized by abnormally enlarged capillary cavities. CCMs can occur as sporadic or familial autosomal dominant form. Familial cases are associated with mutations in CCM1[K-Rev interaction trapped 1 (KRIT1)], CCM2 (MGC4607) and CCM3 (PDCD10) genes. In this study, a three-gene mutation screening was performed by direct exon sequencing, in a cohort of 95 Italian patients either sporadic or familial, as well as on their at-risk relatives. Sixteen mutations in 16 unrelated CCM patients were identified, nine mutations are novel: c.413T > C; c.601C > T; c.846 + 2T > G; c.1254delA; c.1255-4delGTA; c.1681-1682delTA in CCM1; c.48A > G; c.82-83insAG in CCM2; and c.396G > A in CCM3 genes. The samples, negative to direct exon sequencing, were investigated by MLPA to search for intragenic deletions or duplications. One deletion in CCM1 exon 18 was detected in a sporadic patient. Among familial cases 67% had a mutation in CCM1, 5.5% in CCM2, and 5.5% in CCM3, whereas in the remaining 22% no mutations were detected, suggesting the existence of either undetectable mutations or other CCM genes. This study represents the first extensive research program for a comprehensive molecular screening of the three known genes in an Italian cohort of CCM patients and their at-risk relatives.